Labcorp Holdings Inc. (LH)
LH · Health Care ·
United States
Labcorp Holdings Inc. (LH) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 0.45%. Anyone who holds an ETF containing Labcorp Holdings also has an indirect stake in the company.
Data and Charts: Labcorp Holdings
Key Data for Labcorp Holdings
Labcorp Holdings Stock Price Chart
The Labcorp Holdings chart shows daily closing prices and is set to the current year by default. The stock is up 44.0% year to date and up 43.2% over twelve months. The last recorded close on October 30, 2026, was $361.39, at 94% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Labcorp Holdings Stock Performance
| Year to date | +44.0% | 1 year | +43.2% |
|---|---|---|---|
| 1 month | +17.3% | 3 months | +16.9% |
| Calendar year 2025 | +9.4% |
Measured in euros, Labcorp Holdings is up 51.5% year to date and up 48.1% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Labcorp Holdings
What ETF Is Labcorp Holdings In?
Labcorp Holdings has above-average ETF coverage and is held by 22 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 85.1% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 0.45% | €4.51 |
| XDWH | MSCI World Health Care | 0.33% | €3.32 |
| SPFS | MSCI World Health Care | 0.33% | €3.32 |
| XDEW | S&P 500 Equal Weight | 0.22% | €2.23 |
| 2B7K | MSCI World SRI | 0.14% | €1.40 |
| XDEV | MSCI World Value | 0.12% | €1.17 |
| XD9U / XD9D | MSCI USA | 0.05% | €0.45 |
| SPYL / SPY5 | S&P 500 | 0.04% | €0.44 |
| EUNL | MSCI World | 0.04% | €0.40 |
| SXR8 | S&P 500 | 0.04% | €0.40 |
| IUSQ | MSCI ACWI | 0.04% | €0.40 |
| XDWD / XDWL | MSCI World | 0.03% | €0.34 |
| WIMI | MSCI World IMI | 0.03% | €0.33 |
| SWWD | MSCI World | 0.03% | €0.32 |
| SPPW | MSCI World | 0.03% | €0.32 |
| SPYY | MSCI ACWI | 0.03% | €0.27 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Labcorp Holdings, based on each fund's latest holdings list.
US-listed ETFs holding Labcorp Holdings (weight per latest SEC filing): IVV 0.04%, SPY 0.04%, VOO 0.04%, VTI 0.03%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Labcorp Holdings Weight in iShares Core MSCI World (EUNL) Since 2024
In iShares Core MSCI World (EUNL), Labcorp Holdings had a weight of 0.03% on Jun 28, 2024 and 0.04% on Oct 30, 2026. The fund tracks the MSCI World. That is also the stock's highest weight in the period shown. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Labcorp Holdings overlaps with the rest of a portfolio.
Which Tracked Investors Hold Labcorp Holdings?
Labcorp Holdings is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds Labcorp Holdings reduced its position.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 2,798 | $783,440 | reduced by 8,386 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Labcorp Holdings
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Labcorp Holdings | – | – | +43.2% | 23.7% | 6.3% | +7.2% |
| Cooper Companies | 22 | – | -15.1% | 33.3% | 9.2% | +5.1% |
| 22 | – | -5.1% | 29.5% | 8.6% | +7.2% | |
| 22 | – | +30.0% | 34.0% | 25.0% | +21.2% | |
| Agilent Technologies | 21 | – | +22.0% | 31.4% | 18.8% | +6.7% |
| 21 | +0.47 | +23.5% | 38.6% | 8.3% | +5.9% | |
| 21 | – | +21.6% | 32.4% | 21.6% | +4.0% | |
| 21 | – | -20.9% | 25.8% | 12.9% | +11.2% | |
| 21 | – | +9.8% | 38.7% | 28.4% | +16.3% |
These stocks reach a portfolio through largely the same funds as Labcorp Holdings. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Labcorp Holdings
Labcorp Holdings Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 12.2 | 0.4 | 3.4% |
| FY ended Dec 2024 | 13.0 | 0.7 | 5.7% |
| FY ended Dec 2025 | 14.0 | 0.9 | 6.3% |
Technical Analysis: Labcorp Holdings
Labcorp Holdings Risk Metrics
The close on Oct 30, 2026, was 1.8% below the highest close since Aug 12, 2024. That high was reached on Oct 29, 2026. When the S&P 500 rose or fell 1%, Labcorp Holdings moved 0.36% on average in the same direction (past 252 trading days). The correlation of 0.19, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Labcorp Holdings.
What Labcorp Holdings Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Quest Diagnostics Incorporated | +0.67 | |
| Genmab A/S | +0.50 | |
| IQVIA Holdings Inc | +0.47 | |
| Charles River Laboratories International Inc. | +0.44 | |
| Fortive Corp. | +0.44 | |
| Vertex Pharmaceuticals Incorporated | +0.42 | |
| F5 Inc. | -0.33 | |
| Baker Hughes Company Class A | -0.29 | |
| ACH | -0.29 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.


